Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Could BPC-157 help with side effects from GLP-1 agonists
Read guide How BPC-157 interacts at the cellular level based on published in-vitro findings
It is being studied in diabetic neuropathy (NERVARA Phase 2 trial), sarcoidosis, and ischemic injury models
The evidence base is overwhelmingly preclinical, and there are no completed, published Phase 2 or 3 human efficacy trials only early-stage safety work [9]
US$ 22.16
US$ 20.57
US$ 24.76
